News
UCB announces third research collaboration with Harvard University
UCB announced that it has launched a third collaborative research project with Harvard that builds upon the innovative Research Alliance they both signed in...
News
RNA-based therapy brings new hope for an incurable blood...
Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median...
News
Rare disease researchers notch a win for patients with...
An older medication originally approved to treat heart problems eases the symptoms of a very rare muscle disease that often leaves its sufferers stiff...
News
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
Sanofi and Bristol-Myers Squibb Company have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets....
News
New antibiotic cures disease by disarming pathogens
A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead of killing the bacteria that cause it. Researchers report their...
News
Biological markers increase clinical trial success rate of new...
Using biological markers - genetic characteristics that are associated with some patients with breast cancer - can increase the success rate of clinical trials...
News
Bayer’s Stivarga® (regorafenib) tablets approved by FDA for treatment...
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) approved Stivarga® (regorafenib) tablets for the treatment of patients with metastatic colorectal cancer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.